Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for hyperemesis gravidarum
Abstract Background Hyperemesis gravidarum (HG), excessive vomiting in pregnancy, occurs in 0.3–10.8% of pregnancies and is associated with maternal and fetal morbidity. Despite the existence of several off-label treatment options that have shown clinical effectiveness in managing HG symptoms, the v...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2024-12-01
|
| Edice: | BMC Pregnancy and Childbirth |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12884-024-07077-8 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
